Rodrigo Coelho Marques

Rodrigo Coelho Marques

Auto-generated profile, based on publicly available information

Rodrigo Coelho Marques

Universidade Federal de Pernambuco (Recife). Pernambuco, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
RMRodrigo C. Marques
Rodrigo C. Marques
LVLarissa Vieira
Larissa Vieira
DMDéborah Marques
Déborah Marques
ACAmaury Cantilino
Amaury Cantilino
Key words: Prefrontal cortex; medial prefrontal cortex; noninvasive transcranial stimulation; transcranial magnetic stimulation; depression; PTSD; autism spectrum disorder; substance-related disorders; phobic disorders

1 August 2021 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
IPIsabela Pina
Isabela Pina
CBCatarina de M. Braga
Catarina de M. Braga
TOTúlio F.R. de Oliveira
Túlio F.R. de Oliveira
CSCamila N. de Santana
Camila N. de Santana
RMRodrigo C. Marques
Rodrigo C. Marques
LMLeonardo Machado
Leonardo Machado
Objective: Positive psychology interventions (PPIs) incorporate principles of personal strengths with the view that mental health recovery transcends symptom relief. Severe psychiatric conditions, such as schizophrenia, may benefit from such interventions. This study aims to gather the current evidence on the impact of PPIs on increasing well-being in patients on the schizophrenia spectrum and assess reductions in negative or positive symptoms. Methods: A systematic review of PPI studies with schizophrenia-spectrum patients was carried out following PRISMA recommendations. The PubMed, PsycINFO, Web of Science, and Scopus databases were searched for relevant publications in order to understand the possible effects of these interventions on well-being measures and psychotic symptoms in this population. Results: Nine studies (four controlled) were included. Meta-analysis of the controlled studies showed a significant effect (p = 0.04) for improvement of well-being (Z = 2.01). Overall, the reviewed evidence suggests well-being improvement. The effect on reduction of negative symptoms was unclear. Conclusion: Used as an adjunctive therapy, PPIs appear to be a promising resource for patients on the schizophrenia spectrum, with possible effects on well-being and symptom reduction.

1 September 2012 in Revista Brasileira de Educação Médica
Verified
Journal Article
Open access
PDF file
RMRodrigo Coelho Marques
Rodrigo Coelho Marques
EFEuclides Dias Martins Filho
Euclides Dias Martins Filho
GPGuilherme Santos de Paula
Guilherme Santos de Paula
RSRondinneli Roberto dos Santos
Rondinneli Roberto dos Santos
OBJETIVOS: Conhecer a prevalência e as características do assédio moral nas residências médica e não médica em um hospital de ensino em Recife (PE). MÉTODOS: Um questionário foi elaborado para investigar a prevalência do assédio moral, os perfis do assediado e do assediador, e possíveis sequelas. Uma definição para assédio moral foi apresentada aos participantes. RESULTADOS: Foram entrevistados 105 residentes. A prevalência do assédio foi de 41,9%, sendo mais frequente em menores de 28 anos (46,3%), mulheres (45,8%), residentes do segundo ano (47,7%) e na área médica (46,8%). Essas diferenças não foram estatisticamente significantes (p = 0,082; 0,118; 0,349; 0,225, respectivamente). As mulheres referiram mais sequelas (p = 0,013), sendo a maior parte destas de origem psíquica (58,5%) ou profissional (39,0%). Os profissionais responsáveis pela preceptoria são os principais assediadores (40,7%), seguidos daqueles com cargos na coordenação (29,1%; p = < 0,001). CONCLUSÕES: 41,9% dos residentes já foram vítimas de assédio moral. Não houve diferença significativa de prevalência entre os grupos estudados. Os cargos próximos das atividades clínicas se mostraram mais propícios a cometê-lo (preceptoria e coordenação). O sexo feminino se mostrou tão suscetível ao assédio quanto o masculino, mas sofreu significativamente mais sequelas (p = 0,013).

18 July 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
Vitor PalmaresVitor Palmares
Vitor Palmares
Marcelo PalmaresMarcelo Palmares
Marcelo Palmares
CSCarlos Roberto Weber Sobrinho
Carlos Roberto Weber Sobrinho
RMRodrigo Coelho Marques
Rodrigo Coelho Marques
FJFlávio Cardoso de Souza Júnior
Flávio Cardoso de Souza Júnior
MAMarcílio Lins Aroucha
Marcílio Lins Aroucha
Increasing evidence indicates bidirectional communication occurs between the gut and the brain via the microbiome-gut-brain axis. Accordingly, several studies point to a positive effect of probiotics on depressive symptomatology. Our study aimed to provide an updated meta-analysis on the subject. We conducted a systematic search for randomized clinical trials in multiple databases. Data analysis was performed using the Review Manager 5.4. We reviewed 26 studies, totaling 2,170 participants. The use of probiotics had a significant effect in reducing depressive symptoms (SMD: - 0.22; 95% CI: - 0.30 to - 0.13; p < 0.0001) compared to placebo. Subgroup analyses showed that probiotics influenced outcomes in participants with depression (SMD: - 0.67; 95% CI: - 0.93 to - 0.41; p < 0.00001) and with other clinical diagnoses (SMD: - 0.23; 95% CI: - 0.36 to - 0.09; p = 0.0008) but not healthy participants (SMD: - 0.11; 95% CI: - 0.23 to 0.02; p = 0.100). The use of probiotics can be a promising approach in improving the treatment of depression. It is important to conduct further studies to better assess the efficacy of probiotic as an adjuvant treatment to antidepressant medications, as well as their most effective dosages.

15 January 2021 in The Journal of ECT
Verified
Journal Article
Closed access
RMRodrigo C. Marques
Rodrigo C. Marques
DMDéborah Marques
Déborah Marques
LVLarissa Vieira
Larissa Vieira
An abstract is unavailable. This article is available as a PDF only.

1 February 2020 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
RMRodrigo C. Marques
Rodrigo C. Marques
ACAmaury Cantilino
Amaury Cantilino
AZAbraham Zangen
Abraham Zangen
The study in question, conducted by Carmi et al.,2 is the largest randomized controlled trial to date investigating the use of mPFC TMS in the treatment of a psychiatric disorder. In 11 centers across the United States, Canada, and Israel, the researchers tested the efficacy of 20 Hz mPFC TMS in 99 patients with obsessive-compulsive disorder (OCD). The main outcome measure was the Yale-Brown Obsessive Compulsive Scale (YBOCS). Repetitive TMS was performed with an H-coil, which produces deeper and larger stimulation volumes than those of regular coils. Before and during the TMS session, a personalized OCD symptom provocation technique was used to activate the relevant neural circuitry being targeted. The trial design and sample size were based on a pilot study previously completed by part of the same group.3